# Precision Medicine for L/GCMN and Melanoma 1

> **NCT06608420** · — · RECRUITING · sponsor: **Fundacion Clinic per a la Recerca Biomédica** · enrollment: 6000 (estimated)

## Conditions studied

- Melanoma (Skin Cancer)
- Nevi and Melanomas

## Interventions

- **OTHER:** Gradient Boosting Survival Analysis (GBSA),
- **OTHER:** Concordance index

## Key facts

- **NCT ID:** NCT06608420
- **Lead sponsor:** Fundacion Clinic per a la Recerca Biomédica
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-01
- **Primary completion:** 2026-03-01
- **Final completion:** 2026-11-30
- **Target enrollment:** 6000 (ESTIMATED)
- **Last updated:** 2025-02-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06608420

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06608420, "Precision Medicine for L/GCMN and Melanoma 1". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06608420. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
